Physician profile
Rachid Macwar
NPI 1952510729
$6,253.48
in general payments reported to CMS, 2019-2025
31 companies · $145 in 2025
The $145 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,315 · 2020: $987 · 2021: $361 · 2022: $664 · 2023: $1,482 · 2024: $300 · 2025: $145.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,137 · Travel and Lodging: $749 · Consulting Fee: $40.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,137.17 |
| Travel and Lodging | $749.48 |
| Consulting Fee | $40.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Penumbra, INC. | $1,208.92 | 2019-2023 | Indigo System |
| W. L. Gore & Associates, INC. | $895.58 | 2023 | Gore Cardioform Septal Occluder |
| Cardiovascular Systems INC. | $443.71 | 2020-2022 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $441.12 | 2019-2024 | Lifevest |
| Astrazeneca Pharmaceuticals LP | $369.40 | 2019-2025 | Lokelma, Farxiga |
| Abbott Laboratories | $360.14 | 2019-2022 | |
| Novartis Pharmaceuticals Corporation | $309.09 | 2019-2024 | |
| Janssen Pharmaceuticals, INC | $240.47 | 2019-2022 | |
| Shockwave Medical, INC | $218.91 | 2022-2023 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Boston Scientific Corporation | $212.04 | 2019-2024 | |
| E.R. Squibb & Sons, L.L.C. | $197.71 | 2019-2024 | Eliquis, Camzyos |
| Boehringer Ingelheim Pharmaceuticals, INC. | $187.61 | 2020-2023 | Jardiance |
| Celonova Biosciences, INC. | $175.68 | 2019 | |
| Medtronic, INC. | $166.67 | 2021-2024 | Surgipro Ll, Venaseal |
| Abiomed | $135.98 | 2019 |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $125.47 | 2022-2023 | |
| Amarin Pharma, INC. | $86.08 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $79.95 | 2021-2023 | Verquvo |
| Acist Medical Systems, INC. | $63.07 | 2019 | |
| Inari Medical, INC. | $57.51 | 2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Philips North America LLC | $54.35 | 2022-2023 | |
| Vital Connect, INC | $36.45 | 2023-2024 | Vitalpatch Rtm |
| Angiodynamics, INC. | $33.27 | 2023 | Alphavac |
| Astellas Pharma US INC | $30.61 | 2019 | |
| Stryker Corporation | $23.01 | 2025 | Flowtriever |
| Scpharmaceuticals INC. | $21.37 | 2024 | |
| Amgen INC. | $20.77 | 2023 | Repatha |
| Portola Pharmaceuticals, LLC | $18.15 | 2020 | |
| Siemens Medical Solutions USA, INC. | $14.30 | 2023 | Multix Impact |
| Terumo Medical Corporation | $13.10 | 2021 | |
| Asahi Intecc USA, INC. | $12.99 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rachid Macwar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.